NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 21, 2025 Bearish $7.99 X 0
Feb 20, 2025 $8.21 +2.42% $7.92 X 96.29% 0
Feb 20, 2025 $8.14 +1.51% $7.92 X 97.21% 0
Feb 20, 2025 Bullish $7.92 X 0
Feb 6, 2025 $8.85 +2.86% $8.27 X 93.03% 0
Feb 6, 2025 $8.75 +1.79% $8.27 X 94.15% 0
stocks787 stocks787 Amateur
Feb 6, 2025 Bullish $8.27 X 0
stocks787 stocks787 Amateur
Feb 4, 2025 Bullish $8.44 V 1
Jan 10, 2025 $9.34 -2.85% $9.32 V 99.78% 6
Jan 10, 2025 $9.44 -1.80% $9.32 V 98.69% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE